ChatEurope launches live video coverage to bring EU news closer to citizens
ChatEurope, the go-to platform for European affairs created by leading European media outlets, enhances its offer with the launch of key EU events live video coverage.
Kyiv (AFP) | 02/07/2026 - 08:42:54 | Overnight Russian attacks on Kyiv kill at least 13
Seoul (AFP) | 02/07/2026 - 08:41:42 | Seoul stocks plunge 8% as Samsung, SK hynix shares tumble
Doha (AFP) | 02/07/2026 - 06:20:56 | 'Positive progress' in US-Iran indirect talks in Doha: Qatar spokesman
Kyiv (AFP) | 02/07/2026 - 05:41:43 | Death toll from Russian strikes on Ukraine capital rises to 8: authorities
Catia La Mar (AFP) | 02/07/2026 - 05:10:44 | Rescue of trapped Venezuelan underway one week after quakes: AFP reporter
Hong Kong (AFP) | 02/07/2026 - 03:25:11 | South Korean stocks plunge more than 4% on tech rout
Kyiv (AFP) | 02/07/2026 - 03:23:03 | Russian strikes on Ukraine capital kill one: city authorities
Kyiv (AFP) | 02/07/2026 - 01:15:51 | Multiple explosions heard in Kyiv after missile warning: AFP
Paris (AFP) | 01/07/2026 - 23:27:10 | French-German tank maker KNDS says deferring IPO
Kyiv (AFP) | 01/07/2026 - 22:32:25 | Fire breaks out in central Kyiv after explosion: AFP reporter
ChatEurope, the go-to platform for European affairs created by leading European media outlets, enhances its offer with the launch of key EU events live video coverage.
Zambon today announced that the Committee for Medicinal Products for Human Use (CHMP) has adopted a positive opinion recommending the granting of a marketing authorization by the European Medicines Agency (EMA) for Hopledo® (modified-release levodopa/carbidopa) for the treatment of adult patients with Parkinson’s disease and moderate to severe motor fluctuations who have not been sufficiently stabilized with oral levodopa/DDC inhibitor-based treatment regimens. CHMP recommendation is based on...
Enhertu® (trastuzumab deruxtecan) has been approved in the European Union (EU) as a monotherapy for the treatment of adult patients with unresectable or metastatic HER2 positive (immunohistochemistry [IHC] 3+) solid tumors who have received prior treatment and who have no satisfactory treatment options. Enhertu is a specifically engineered HER2 directed DXd antibody drug conjugate (ADC) discovered by Daiichi Sankyo (TSE: 4568) and being jointly developed and commercialized by Daiichi Sankyo a...
The Korean Patent Court has invalidated three of Aspen Aerogels’ patents related to improved hydrophobic aerogel material. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260628192007/en/Beerenberg delivers high-end insulation solutions built for performance, reliability, and long-term value. (Photo: Beerenberg) The ruling confirms the conclusion of the Intellectual Property Trial and Appeal Board (IPTAB) that the patents did not mee...
COOCON (CEO Kim Jong-hyun, KOSDAQ: 294570), a business data platform company in South Korea, announced on June 29 that it is accelerating its push into the Model Context Protocol (MCP)-based data business for the AI agent era. Under the plan, COOCON aims to grow into a “dedicated data hub for AI agents” by delivering its existing data in MCP format so AI agents can utilize it directly. With over 20 years of expertise in collecting and connecting data across finance, the public sector, logisti...
Seiden Law LLP (“Seiden Law”), legal counsel for Mr. Leak Yim, a Cambodia national, and his family, announces the filing of an application in U.S. federal district court in Washington D.C., seeking court-ordered discovery to uncover the false and misleading information that may have led to mistaken prosecution in Thailand of Mr. Yim as well as his unwarranted identification to Congress as being associated with scam centers in Asia. 28 U.S.C. § 1782 (“1782”) provides powerful evidence-gatherin...
Samsung Bioepis Co., Ltd. announced today that the Phase 1 and Phase 3 studies on SB27, a proposed biosimilar to Keytruda1 (pembrolizumab), have met their primary endpoints. “We are excited to announce preliminary results from the Phase 1 and Phase 3 studies for SB27, our pembrolizumab biosimilar candidate. These topline positive results reinforce our scientific expertise and leadership in biosimilar development,” said Donghoon Shin, Executive Vice President and Head of Clinical Sciences Divi...
Doubtless launches today with the goal of helping more pet parents across the world access quality care for the pets they love. The company brings together a leading global portfolio of pet insurance brands with a growing range of connected solutions designed to support pet parents at every stage of their pet’s life. With over 4,000 employees, Doubtless insures 6 million pets across 10 markets in North America, Europe and the United Kingdom. “Uncertainty about the financial commitments associ...
IQM today announced it has been named a Major Player in the IDC MarketScape: Worldwide Quantum Computing 2026 Vendor Assessment. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260629748732/en/IQM named a major player in the IDC MarketScape IQM believes this recognition comes as institutions worldwide move quantum computing out of shared cloud access and into infrastructure they own and operate themselves. IQM calls this Production Q...